Literature DB >> 17032565

Pediatric headache.

Jack Gladstein1.   

Abstract

Migraine is very treatable in children and adolescents. Principles of treatment include early intervention, elimination of triggers, involvement of parents and schools, and judicious use of medicines. Although there is no pediatric indication in the United States, triptans are safe and effective in this age group. Prophylactic drugs should be used when significant disability from migraine exists. Choice of drug is based upon comorbidity. Nonpharmacologic treatment has an important role.

Entities:  

Year:  2006        PMID: 17032565     DOI: 10.1007/s11940-006-0034-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  34 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.

Authors:  Paul Winner; Donald Lewis; W Hester Visser; Kaihong Jiang; Suzanne Ahrens; Judith K Evans
Journal:  Headache       Date:  2002-01       Impact factor: 5.887

Review 3.  Pediatric migraine: recognition and treatment.

Authors:  Andrew D Hershey; Paul K Winner
Journal:  J Am Osteopath Assoc       Date:  2005-04

Review 4.  The role of imaging in the pathophysiology and diagnosis of headache.

Authors:  Arne May
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

5.  Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses.

Authors:  Scott W Powers; Susana R Patton; Kevin A Hommel; Andrew D Hershey
Journal:  Pediatrics       Date:  2003-07       Impact factor: 7.124

Review 6.  Anticonvulsants in migraine.

Authors:  William B Young; Hua Chiang Siow; Stephen D Silberstein
Journal:  Curr Pain Headache Rep       Date:  2004-06

7.  Prophylactic treatment of pediatric migraine.

Authors:  Donald W Lewis; Sharon Diamond; David Scott; Valarie Jones
Journal:  Headache       Date:  2004-03       Impact factor: 5.887

Review 8.  The pharmacological treatment options for pediatric migraine: an evidence-based appraisal.

Authors:  Donald W Lewis; Paul Winner
Journal:  NeuroRx       Date:  2006-04

9.  Sodium valproate prophylaxis in childhood migraine.

Authors:  Gul Serdaroglu; Elvan Erhan; Hasan Tekgul; Figen Oksel; Serpil Erermis; Meltem Uyar; Sarenur Tutuncuoglu
Journal:  Headache       Date:  2002-09       Impact factor: 5.887

10.  Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety.

Authors:  James A Charles
Journal:  J Headache Pain       Date:  2006-04-26       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.